Gliomas are the most common type of malignant primary brain tumor. Imaging is crucial in diagnosing gliomas and evaluating treatment responses. Proper application and customization of the RANO and RAPNO criteria for each unique clinical trial, including criteria clarifications and… Read More
Imaging is vital for diagnosing, staging, and monitoring multiple myeloma (MM) in clinical trials. Common imaging methods include Whole-Body Low-Dose CT, ideal for initial MM-related lytic bone lesion assessment; MRI, the gold standard for detecting bone marrow involvement; and 18F-FDG… Read More
Colorectal cancer (CRC) is the third most frequent cancer diagnosed in the world, and the second most frequent cause of death related to cancer. Imaging has a critical role in diagnosis, determining stage of the disease, selecting treatment strategies, and… Read More
Medical imaging is pivotal in clinical trials for gastric cancer, where precise staging and response evaluation are essential. Imaging technologies like CT, MRI, and PET are integrated into clinical trials, typically using Response Evaluation Criteria in Solid Tumors (RECIST). These… Read More
The assessment of peritoneal metastasis in ovarian cancer is a critical challenge in clinical trials. Inaccurate evaluations can lead to significant discrepancies in treatment responses and patient management. Recent discussions, including insights from Dr. M. Sharma and colleagues at ECR25,… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
